We’re pleased to share the latest CIRS newsletter with you, featuring updates from our recent workshops, global engagements, and research studies advancing medicine regulation and HTA.
🔍 What’s Inside:
- Joint Clinical Assessment Workshop: Our November meeting in Amsterdam brought together EU HTA agencies and other stakeholders to discuss integrating JCA outputs into national decision making.
- Industry Technical Forum: Member companies explored the potential implications of major policy changes, including the EU Pharmaceutical Legislation reform and US MFN policy.
- Patient Involvement Workshop: October’s workshop near London focused on the impact and visibility of patient engagement and experience data in regulatory and HTA decision making.
- Global Engagements: Insights from CIRS research were shared at various conferences globally and with agencies across Asia.
- Thought Leadership: A roundup of our 2025 publications and R&D Briefings, including comparative studies on regulatory timelines, HTA trends, and best practices worldwide.
